Arbor Vita Corporation's research programs focus on diseases linked to the role of PDZ proteins in cell signaling pathways. AVC has selected three disease areas for drug and/or diagnostic development: Neurology, Oncology and Infectious Diseases. These were selected based on several criteria:

AVC Influenza Diagnostics
NA-1 Neuroischemia Therapeutic
AVC AVantage HPV E6 Test
  • Clear clinical indication with significant unmet need
  • A PDZ protein plays a significant role in the disease process
  • A PDZ approach provides a unique advantage; for example: higher efficacy, lower side effects, higher specificity